Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement.
Abilities to successfully quit smoking display substantial evidence for heritability in classic and molecular genetic studies. Genome-wide association (GWA) studies have demonstrated single-nucleotide polymorphisms (SNPs) and haplotypes that distinguish successful quitters from individuals who were unable to quit smoking in clinical trial participants and in community samples. Many of the subjects in these clinical trial samples were aided by nicotine replacement therapy (NRT). We now report novel GWA results from participants in a clinical trial that sought dose/response relationships for "precessation" NRT. In this trial, 369 European-American smokers were randomized to 21 or 42 mg NRT, initiated 2 wks before target quit dates. Ten-week continuous smoking abstinence was assessed on the basis of self-reports and carbon monoxide levels. SNP genotyping used Affymetrix 6.0 arrays. GWA results for smoking cessation success provided no P value that reached "genome-wide" significance. Compared with chance, these results do identify (a) more clustering of nominally positive results within small genomic regions, (b) more overlap between these genomic regions and those identified in six prior successful smoking cessation GWA studies and (c) sets of genes that fall into gene ontology categories that appear to be biologically relevant. The 1,000 SNPs with the strongest associations form a plausible Bayesian network; no such network is formed by randomly selected sets of SNPs. The data provide independent support, based on individual genotyping, for many loci previously nominated on the basis of data from genotyping in pooled DNA samples. These results provide further support for the idea that aid for smoking cessation may be personalized on the basis of genetic predictors of outcome.
Uhl
George R
GR
Molecular Neurobiology Branch, National Institutes of Health Intramural Research Program, National Institute on Drug Abuse (NIH-IRP, NIDA), Baltimore, Maryland, United States of America. guhl@intra.nida.nih.gov
Drgon
Tomas
T
Johnson
Catherine
C
Ramoni
Marco F
MF
Behm
Frederique M
FM
Rose
Jed E
JE
D000328:Adult; D001499:Bayes Theorem; D002248:Carbon Monoxide / Q000032:analysis; D005820:Genetic Testing; D055106:Genome-Wide Association Study; D005838:Genotype; D006801:Humans; D009538:Nicotine / Q000627:therapeutic use*; D020641:Polymorphism, Single Nucleotide; D012907:Smoking / Q000235:genetics* / Q000628:therapy*; D016540:Smoking Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000235:genetics; D016896:Treatment Outcome
D009538:Nicotine; D002248:Carbon Monoxide
Arch Gen Psychiatry. 2008 Mar;65(3):345-55
18316681
Thorax. 2007 Oct;62(10):898-903
17483139
Psychol Med. 2004 Jul;34(5):865-79
15500307
Nat Genet. 2008 May;40(5):616-22
18385676
Am J Prev Med. 2000 May;18(4):305-11
10788733
Mol Med. 2009 Jan-Feb;15(1-2):21-7
19009022
Nat Genet. 2010 May;42(5):448-53
20418888
J Am Med Inform Assoc. 2009 May-Jun;16(3):371-9
19261943
Arch Gen Psychiatry. 2008 Jun;65(6):683-93
18519826
MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1226-8
19008791
Nucleic Acids Res. 2009 Jan;37(Database issue):D251-60
18790807
Twin Res Hum Genet. 2006 Feb;9(1):64-72
16611469
Mol Med. 2009 Jul-Aug;15(7-8):268-74
19593411
J Hum Genet. 2009 Nov;54(11):615-23
19851339
Pharmacogenomics. 2009 Sep;10(9):1393-412
19761364
Pharmacogenomics. 2010 Mar;11(3):357-67
20235792
Ann N Y Acad Sci. 2008 Oct;1141:318-81
18991966
J Neurogenet. 2009;23(3):283-92
19184766
Control Clin Trials. 1990 Apr;11(2):116-28
2161310
Stroke. 2009 Mar;40(3 Suppl):S67-70
19064790
BMC Genet. 2007 Apr 03;8:10
17407593
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):918-25
17099884
Nat Genet. 2010 May;42(5):441-7
20418890
Hum Mol Genet. 2007 Jan 1;16(1):24-35
17158188
Am J Hum Genet. 2007 Sep;81(3):559-75
17701901
Nature. 2008 Apr 3;452(7187):638-642
18385739
Mol Psychiatry. 2009 Jul;14(7):653-67
19238150
Nat Genet. 2010 May;42(5):436-40
20418889
Control Clin Trials. 1998 Dec;19(6):589-601
9875838
Mol Med. 2010 Jul-Aug;16(7-8):247-53
20379614